ISRCTN35255420
Completed
Phase 1
Clinical evaluation of a novel LiveOCT (Optical Coherence Tomography) device to improve the management of eye disease
niversity of Liverpool0 sites90 target enrollmentOctober 21, 2021
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Corneal diseases
- Sponsor
- niversity of Liverpool
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 12 years or above
- •2\. Diagnosis of either Fuchs endothelial corneal dystrophy (FECD) or corneal lamellar surgery, Keratoconus, or no known corneal disease (healthy volunteers)
Exclusion Criteria
- •1\. Nystagmus
- •2\. Inability to provide informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical evaluation of newly developed, optical-fiber based FFR device, comparing with conventional FFR devise using piezo electric sensors.coronary artery disease patientsJPRN-UMIN000021502agoya University Graduate School of Medicine50
Recruiting
Not Applicable
The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomographyaccessory visual structuresJPRN-UMIN000019294Kyoto University Graduate School of Medicine130
Recruiting
Not Applicable
Development and clinical application of an optical mouse detection device for the treatment of amblyopia caused by congenital nystagmus, sway vision in acquired nystagmus, and reduction of diplopia in acquired strabismusCongenital nystagmus, acquired nystagmus, strabismusJPRN-UMIN000046924Kitasato University School of Allied Health Sciences40
Not yet recruiting
Not Applicable
Evaluating outcomes of optic capture (modification of cataract surgery) in pediatric cataract surgery.Health Condition 1: H28- Cataract in diseases classified elsewhereCTRI/2024/01/061648Dr Neha Sachin Sapar
Recruiting
Not Applicable
European trial on Optical Coherence Tomography Optimized Bifurcation Event ReductioNL-OMON55628Aarhus University Hospital140